ValiRx (LON:VAL) Releases Earnings Results

ValiRx (LON:VAL) issued its earnings results on Monday. The company reported GBX (0.54) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The company had revenue of GBX 3 million during the quarter. ValiRx had a negative return on equity of 45.91% and a negative net margin of 3,582.56%.

ValiRx Stock Performance

Shares of LON:VAL opened at GBX 0.17 on Wednesday. The business’s fifty day moving average price is GBX 0.23 and its two-hundred day moving average price is GBX 0.30. ValiRx has a fifty-two week low of GBX 0.16 and a fifty-two week high of GBX 0.85. The stock has a market capitalization of £1.28 million, a price-to-earnings ratio of -0.18 and a beta of 0.59. The company has a debt-to-equity ratio of 0.19, a current ratio of 9.66 and a quick ratio of 1.27.

About ValiRx

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.